ヒト免疫不全ウイルス（HIV）の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Human Immunodeficiency Virus(HIV) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-02736 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、ヒト免疫不全ウイルス（HIV）の世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒト免疫不全ウイルス（HIV）の種類別市場規模（診断、治療）、用途別市場規模（病院、外来手術センター、診断センター、在宅医療施設、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Gilead、Genentech、Merck、GlaxoSmithKline、Boehringer Ingelheim、Johnson & Johnson、Bristol-Myers Squibb、AbbVie、Cipla ・地域別グローバル市場分析 2015年-2020年 ・ヒト免疫不全ウイルス（HIV）の北米市場（アメリカ、カナダ、メキシコ） ・ヒト免疫不全ウイルス（HIV）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ヒト免疫不全ウイルス（HIV）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ヒト免疫不全ウイルス（HIV）の南米市場（ブラジル、アルゼンチン） ・ヒト免疫不全ウイルス（HIV）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：診断、治療 ・用途別分析：病院、外来手術センター、診断センター、在宅医療施設、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Human Immunodeficiency Virus(HIV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Human Immunodeficiency Virus(HIV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Human Immunodeficiency Virus(HIV) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Human Immunodeficiency Virus(HIV) market has been segmented into:
Diagnosis
Treatment

By Application, Human Immunodeficiency Virus(HIV) has been segmented into:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Immunodeficiency Virus(HIV) market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Immunodeficiency Virus(HIV) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Immunodeficiency Virus(HIV) market.

The report offers in-depth assessment of the growth and other aspects of the Human Immunodeficiency Virus(HIV) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Human Immunodeficiency Virus(HIV) Market Share Analysis
Human Immunodeficiency Virus(HIV) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Immunodeficiency Virus(HIV) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Immunodeficiency Virus(HIV) sales, revenue and market share for each player covered in this report.

The major players covered in Human Immunodeficiency Virus(HIV) are:
Gilead
Genentech
Merck
GlaxoSmithKline
Boehringer Ingelheim
Johnson & Johnson
Bristol-Myers Squibb
AbbVie
Cipla

レポート目次

---

Table of Contents

1 Human Immunodeficiency Virus(HIV) Market Overview
1.1 Product Overview and Scope of Human Immunodeficiency Virus(HIV)
1.2 Classification of Human Immunodeficiency Virus(HIV) by Type
1.2.1 Global Human Immunodeficiency Virus(HIV) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Type in 2019
1.2.3 Diagnosis
1.2.4 Treatment
1.3 Global Human Immunodeficiency Virus(HIV) Market by Application
1.3.1 Overview: Global Human Immunodeficiency Virus(HIV) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Homecare Settings
1.3.6 Others
1.4 Global Human Immunodeficiency Virus(HIV) Market by Regions
1.4.1 Global Human Immunodeficiency Virus(HIV) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Human Immunodeficiency Virus(HIV) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Human Immunodeficiency Virus(HIV) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Human Immunodeficiency Virus(HIV) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Immunodeficiency Virus(HIV) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Human Immunodeficiency Virus(HIV) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Immunodeficiency Virus(HIV) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Gilead
2.1.1 Gilead Details
2.1.2 Gilead Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Gilead SWOT Analysis
2.1.4 Gilead Product and Services
2.1.5 Gilead Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genentech
2.2.1 Genentech Details
2.2.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genentech SWOT Analysis
2.2.4 Genentech Product and Services
2.2.5 Genentech Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Boehringer Ingelheim SWOT Analysis
2.5.4 Boehringer Ingelheim Product and Services
2.5.5 Boehringer Ingelheim Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bristol-Myers Squibb SWOT Analysis
2.7.4 Bristol-Myers Squibb Product and Services
2.7.5 Bristol-Myers Squibb Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2018-2019)
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AbbVie SWOT Analysis
2.8.4 AbbVie Product and Services
2.8.5 AbbVie Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cipla SWOT Analysis
2.9.4 Cipla Product and Services
2.9.5 Cipla Human Immunodeficiency Virus(HIV) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Human Immunodeficiency Virus(HIV) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Immunodeficiency Virus(HIV) Players Market Share
3.2.2 Top 10 Human Immunodeficiency Virus(HIV) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Human Immunodeficiency Virus(HIV) Revenue and Market Share by Regions
4.2 North America Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
4.3 Europe Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
4.5 South America Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
5 North America Human Immunodeficiency Virus(HIV) Revenue by Countries
5.1 North America Human Immunodeficiency Virus(HIV) Revenue by Countries (2015-2020)
5.2 USA Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
5.3 Canada Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
5.4 Mexico Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
6 Europe Human Immunodeficiency Virus(HIV) Revenue by Countries
6.1 Europe Human Immunodeficiency Virus(HIV) Revenue by Countries (2015-2020)
6.2 Germany Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
6.3 UK Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
6.4 France Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
6.5 Russia Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
6.6 Italy Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue by Countries
7.1 Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue by Countries (2015-2020)
7.2 China Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
7.3 Japan Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
7.4 Korea Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
7.5 India Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
8 South America Human Immunodeficiency Virus(HIV) Revenue by Countries
8.1 South America Human Immunodeficiency Virus(HIV) Revenue by Countries (2015-2020)
8.2 Brazil Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
8.3 Argentina Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Human Immunodeficiency Virus(HIV) by Countries
9.1 Middle East & Africa Human Immunodeficiency Virus(HIV) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
9.3 UAE Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
9.4 Egypt Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
9.5 South Africa Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Human Immunodeficiency Virus(HIV) Revenue and Market Share by Type (2015-2020)
10.2 Global Human Immunodeficiency Virus(HIV) Market Forecast by Type (2019-2024)
10.3 Diagnosis Revenue Growth Rate (2015-2025)
10.4 Treatment Revenue Growth Rate (2015-2025)
11 Global Human Immunodeficiency Virus(HIV) Market Segment by Application
11.1 Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Application (2015-2020)
11.2 Human Immunodeficiency Virus(HIV) Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
11.6 Homecare Settings Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Human Immunodeficiency Virus(HIV) Market Size Forecast (2021-2025)
12.1 Global Human Immunodeficiency Virus(HIV) Market Size Forecast (2021-2025)
12.2 Global Human Immunodeficiency Virus(HIV) Market Forecast by Regions (2021-2025)
12.3 North America Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2021-2025)
12.4 Europe Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2021-2025)
12.6 South America Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Human Immunodeficiency Virus(HIV) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Immunodeficiency Virus(HIV) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Immunodeficiency Virus(HIV) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Human Immunodeficiency Virus(HIV) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Gilead Corporate Information, Location and Competitors
Table 6. Gilead Human Immunodeficiency Virus(HIV) Major Business
Table 7. Gilead Human Immunodeficiency Virus(HIV) Total Revenue (USD Million) (2017-2018)
Table 8. Gilead SWOT Analysis
Table 9. Gilead Human Immunodeficiency Virus(HIV) Product and Solutions
Table 10. Gilead Human Immunodeficiency Virus(HIV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Genentech Corporate Information, Location and Competitors
Table 12. Genentech Human Immunodeficiency Virus(HIV) Major Business
Table 13. Genentech Human Immunodeficiency Virus(HIV) Total Revenue (USD Million) (2018-2019)
Table 14. Genentech SWOT Analysis
Table 15. Genentech Human Immunodeficiency Virus(HIV) Product and Solutions
Table 16. Genentech Human Immunodeficiency Virus(HIV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Human Immunodeficiency Virus(HIV) Major Business
Table 19. Merck Human Immunodeficiency Virus(HIV) Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Human Immunodeficiency Virus(HIV) Product and Solutions
Table 22. Merck Human Immunodeficiency Virus(HIV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GlaxoSmithKline Corporate Information, Location and Competitors
Table 24. GlaxoSmithKline Human Immunodeficiency Virus(HIV) Major Business
Table 25. GlaxoSmithKline Human Immunodeficiency Virus(HIV) Total Revenue (USD Million) (2017-2018)
Table 26. GlaxoSmithKline SWOT Analysis
Table 27. GlaxoSmithKline Human Immunodeficiency Virus(HIV) Product and Solutions
Table 28. GlaxoSmithKline Human Immunodeficiency Virus(HIV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 30. Boehringer Ingelheim Human Immunodeficiency Virus(HIV) Major Business
Table 31. Boehringer Ingelheim Human Immunodeficiency Virus(HIV) Total Revenue (USD Million) (2017-2018)
Table 32. Boehringer Ingelheim SWOT Analysis
Table 33. Boehringer Ingelheim Human Immunodeficiency Virus(HIV) Product and Solutions
Table 34. Boehringer Ingelheim Human Immunodeficiency Virus(HIV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Johnson & Johnson Corporate Information, Location and Competitors
Table 36. Johnson & Johnson Human Immunodeficiency Virus(HIV) Major Business
Table 37. Johnson & Johnson Human Immunodeficiency Virus(HIV) Total Revenue (USD Million) (2017-2018)
Table 38. Johnson & Johnson SWOT Analysis
Table 39. Johnson & Johnson Human Immunodeficiency Virus(HIV) Product and Solutions
Table 40. Johnson & Johnson Human Immunodeficiency Virus(HIV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 42. Bristol-Myers Squibb Human Immunodeficiency Virus(HIV) Major Business
Table 43. Bristol-Myers Squibb Human Immunodeficiency Virus(HIV) Total Revenue (USD Million) (2017-2018)
Table 44. Bristol-Myers Squibb SWOT Analysis
Table 45. Bristol-Myers Squibb Human Immunodeficiency Virus(HIV) Product and Solutions
Table 46. Bristol-Myers Squibb Human Immunodeficiency Virus(HIV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AbbVie Corporate Information, Location and Competitors
Table 48. AbbVie Human Immunodeficiency Virus(HIV) Major Business
Table 49. AbbVie Human Immunodeficiency Virus(HIV) Total Revenue (USD Million) (2017-2018)
Table 50. AbbVie SWOT Analysis
Table 51. AbbVie Human Immunodeficiency Virus(HIV) Product and Solutions
Table 52. AbbVie Human Immunodeficiency Virus(HIV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Cipla Corporate Information, Location and Competitors
Table 54. Cipla Human Immunodeficiency Virus(HIV) Major Business
Table 55. Cipla Human Immunodeficiency Virus(HIV) Total Revenue (USD Million) (2017-2018)
Table 56. Cipla SWOT Analysis
Table 57. Cipla Human Immunodeficiency Virus(HIV) Product and Solutions
Table 58. Cipla Human Immunodeficiency Virus(HIV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Human Immunodeficiency Virus(HIV) Revenue (Million USD) by Players (2015-2020)
Table 60. Global Human Immunodeficiency Virus(HIV) Revenue Share by Players (2015-2020)
Table 61. Global Human Immunodeficiency Virus(HIV) Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Regions (2015-2020)
Table 63. North America Human Immunodeficiency Virus(HIV) Revenue by Countries (2015-2020)
Table 64. North America Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries (2015-2020)
Table 65. Europe Human Immunodeficiency Virus(HIV) Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Human Immunodeficiency Virus(HIV) Revenue by Countries (2015-2020)
Table 68. South America Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Human Immunodeficiency Virus(HIV) Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries (2015-2020)
Table 71. Global Human Immunodeficiency Virus(HIV) Revenue (Million USD) by Type (2015-2020)
Table 72. Global Human Immunodeficiency Virus(HIV) Revenue Share by Type (2015-2020)
Table 73. Global Human Immunodeficiency Virus(HIV) Revenue Forecast by Type (2021-2025)
Table 74. Global Human Immunodeficiency Virus(HIV) Revenue by Application (2015-2020)
Table 75. Global Human Immunodeficiency Virus(HIV) Revenue Share by Application (2015-2020)
Table 76. Global Human Immunodeficiency Virus(HIV) Revenue Forecast by Application (2021-2025)
Table 77. Global Human Immunodeficiency Virus(HIV) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Human Immunodeficiency Virus(HIV) Picture
Figure 2. Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Type in 2019
Figure 3. Diagnosis Picture
Figure 4. Treatment Picture
Figure 5. Human Immunodeficiency Virus(HIV) Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers Picture
Figure 8. Diagnostic Centers Picture
Figure 9. Homecare Settings Picture
Figure 10. Others Picture
Figure 11. Global Human Immunodeficiency Virus(HIV) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Human Immunodeficiency Virus(HIV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Human Immunodeficiency Virus(HIV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Human Immunodeficiency Virus(HIV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Human Immunodeficiency Virus(HIV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Human Immunodeficiency Virus(HIV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Human Immunodeficiency Virus(HIV) Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Human Immunodeficiency Virus(HIV) Revenue Market Share in 2019
Figure 20. Global Top 10 Players Human Immunodeficiency Virus(HIV) Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Human Immunodeficiency Virus(HIV) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Regions (2015-2020)
Figure 24. Global Human Immunodeficiency Virus(HIV) Revenue Market Share by Regions in 2018
Figure 25. North America Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 26. Europe Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 28. South America Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 30. North America Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries (2015-2020)
Figure 31. North America Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries in 2019
Figure 32. USA Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 33. Canada Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 35. Europe Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries in 2019
Figure 37. Germany Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 38. UK Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 39. France Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 40. Russia Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 41. Italy Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries in 2019
Figure 44. China Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 45. Japan Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 46. Korea Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 47. India Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 49. South America Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries (2015-2020)
Figure 50. South America Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries in 2019
Figure 51. Brazil Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Human Immunodeficiency Virus(HIV) Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 56. UAE Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Human Immunodeficiency Virus(HIV) Revenue and Growth Rate (2015-2020)
Figure 59. Global Human Immunodeficiency Virus(HIV) Revenue Share by Type (2015-2020)
Figure 60. Global Human Immunodeficiency Virus(HIV) Revenue Share by Type in 2019
Figure 61. Global Human Immunodeficiency Virus(HIV) Market Share Forecast by Type (2021-2025)
Figure 62. Global Diagnosis Revenue Growth Rate (2015-2020)
Figure 63. Global Treatment Revenue Growth Rate (2015-2020)
Figure 64. Global Human Immunodeficiency Virus(HIV) Revenue Share by Application (2015-2020)
Figure 65. Global Human Immunodeficiency Virus(HIV) Revenue Share by Application in 2019
Figure 66. Global Human Immunodeficiency Virus(HIV) Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 69. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Homecare Settings Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Human Immunodeficiency Virus(HIV) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Human Immunodeficiency Virus(HIV) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Human Immunodeficiency Virus(HIV) Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2021-2025)
Figure 76. Europe Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2021-2025)
Figure 78. South America Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Human Immunodeficiency Virus(HIV) Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---